Clinical trial
Heparin-Induced Thrombocytopenia Registry
NCT00456326 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00456326 |
|---|---|
| Title | Heparin-Induced Thrombocytopenia Registry |
| Official title | A 3 Year Retrospective Heparin Induced Thrombocytopenia Registry (HIT) at Brigham and Women's Hospital. |
| Acronym | HIT |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Heparin-Induced Thrombocytopenia |
| Enrollment | 242 |
| Start date | Oct 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Apr 4, 2007 |
| Last update posted | Feb 18, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: